JPRN-UMIN000047550已完成未知
Open-label, multicenter, randomized, parallel-group comparative study for the utility of telephone follow-up in community pharmacies for the detection of triple whammy in multiple drug combination patients - Comparison of concomitant drug confirmation methods in community pharmacies for detection of triple whammy in multiple drug combination patients
Shiga Pharmaceutical Association Kaiei Pharmacy0 个研究点目标入组 80 人开始时间: 2022年4月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who failed to obtain consent to the study 2. Patients or agents unable to respond to telephone calls, such as cognitive decline or hearing loss
研究者
相似试验
进行中（未招募）
不适用
To examine the user satisfaction and tolerability in women 18 to 29 years of age using LCS12 compared to women using Yasmin® over 18 months. Additionally bleeding patterns and adverse event profile will be assessed.The aim of the present study is to examine the overall satisfaction with and tolerability of LCS12 compared with a standard combined oral contraceptive (COCYasmin30 µg ethinyl estradiol and 3 mg drospirenone) regimen in young nulliparous and parous women aged 18-29 years.MedDRA version: 14.0Level: PTClassification code 10010808Term: ContraceptionSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2010-020181-21-ATBayer HealthCare AG550
进行中（未招募）
不适用
To examine the user satisfaction and tolerability in women 18 to 29 years of age using LCS12 compared to women using Yasmin® over 18 months. Additionally bleeding patterns and adverse event profile will be assessed.The aim of the present study is to examine the overall satisfaction with and tolerability of LCS12 compared with a standard combined oral contraceptive (COCYasmin30 µg ethinyl estradiol and 3 mg drospirenone) regimen in young nulliparous and parous women aged 18-29 years.MedDRA version: 14.0Level: PTClassification code 10010808Term: ContraceptionSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2010-020181-21-BEBayer HealthCare AG550
进行中（未招募）
不适用
To examine the user satisfaction and tolerability in women 18 to 29 years of age using LCS12 compared to women using Yasmin® over 18 months. Additionally bleeding patterns and adverse event profile will be assessed.The aim of the present study is to examine the overall satisfaction with and tolerability of LCS12 compared with a standard combined oral contraceptive (COCYasmin30 µg ethinyl estradiol and 3 mg drospirenone) regimen in young nulliparous and parous women aged 18-29 years.MedDRA version: 14.0Level: PTClassification code 10010808Term: ContraceptionSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2010-020181-21-DEBayer HealthCare AG550
未知
2 期
Multicenter, randomized, open-label, parallel-group study to compare mLSG15 + KW-0761 to mLSG15JPRN-jRCT2080221172Kyowa Hakko Kirin Co., Ltd.
进行中（未招募）
不适用
Multicenter, randomised, open-label, parallel group, controlled study to evaluate the efficacy, tollerability and safety of BioFOAM dressing containing larve of Lucilia sericata in patients with chronic, vascular ulcers with/without evident infection versus standard treatment (idrogel. - NDPatient with venous ulcers or mixed aetiology ulcers containig necrotic tissueMedDRA version: 9.1Level: LLTClassification code 10066677Term: Chronic leg ulcerEUCTR2008-006076-30-ITASL 2 SAVONESE